Market Closed -
Nyse
04:00:02 2024-05-16 pm EDT
|
5-day change
|
1st Jan Change
|
0.4862
USD
|
+1.57%
|
|
-5.13%
|
-67.37%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
5,951
|
1,570
|
779.4
|
428.5
|
144.1
|
-
|
-
|
Enterprise Value (EV)
1 |
4,910
|
823.7
|
240.9
|
56.44
|
-105.3
|
-63.05
|
-56.66
|
P/E ratio
|
-11.2
x
|
-8.75
x
|
-2.86
x
|
-0.63
x
|
-0.6
x
|
-1.06
x
|
-1.75
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
24.3
x
|
6.21
x
|
2.81
x
|
1.65
x
|
0.55
x
|
0.44
x
|
0.39
x
|
EV / Revenue
|
20
x
|
3.26
x
|
0.87
x
|
0.22
x
|
-0.4
x
|
-0.19
x
|
-0.15
x
|
EV / EBITDA
|
-53
x
|
-6.71
x
|
-1.37
x
|
-0.34
x
|
0.67
x
|
1.04
x
|
2.35
x
|
EV / FCF
|
-42.4
x
|
-5.8
x
|
-1.25
x
|
-0.35
x
|
0.6
x
|
1.1
x
|
-4.93
x
|
FCF Yield
|
-2.36%
|
-17.3%
|
-80%
|
-290%
|
167%
|
90.9%
|
-20.3%
|
Price to Book
|
4.88
x
|
1.28
x
|
0.74
x
|
0.93
x
|
0.5
x
|
0.68
x
|
0.83
x
|
Nbr of stocks (in thousands)
|
234,956
|
259,959
|
275,410
|
287,569
|
296,463
|
-
|
-
|
Reference price
2 |
25.33
|
6.040
|
2.830
|
1.490
|
0.4862
|
0.4862
|
0.4862
|
Announcement Date
|
3/24/21
|
2/24/22
|
2/22/23
|
2/14/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
148.9
|
245.3
|
252.8
|
277.2
|
259
|
261.7
|
324
|
366.2
|
EBITDA
1 |
-
|
-92.69
|
-122.7
|
-175.3
|
-165.4
|
-157.9
|
-60.79
|
-24.14
|
EBIT
1 |
-
|
-219
|
-179.1
|
-275.9
|
-692.1
|
-249.4
|
-153.7
|
-107.8
|
Operating Margin
|
-
|
-89.3%
|
-70.87%
|
-99.51%
|
-267.19%
|
-95.29%
|
-47.43%
|
-29.42%
|
Earnings before Tax (EBT)
1 |
-
|
-225.8
|
-179
|
-269.7
|
-672.7
|
-240.8
|
-148.2
|
-103.4
|
Net income
1 |
-87.19
|
-224.4
|
-176.3
|
-270.4
|
-675.2
|
-237.9
|
-139.5
|
-81.48
|
Net margin
|
-58.57%
|
-91.51%
|
-69.76%
|
-97.56%
|
-260.63%
|
-90.88%
|
-43.05%
|
-22.25%
|
EPS
2 |
-2.119
|
-2.270
|
-0.6900
|
-0.9900
|
-2.380
|
-0.8050
|
-0.4605
|
-0.2772
|
Free Cash Flow
1 |
-
|
-115.8
|
-142.1
|
-192.6
|
-163.6
|
-175.9
|
-57.3
|
11.49
|
FCF margin
|
-
|
-47.21%
|
-56.21%
|
-69.49%
|
-63.15%
|
-67.22%
|
-17.68%
|
3.14%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/24/20
|
3/24/21
|
2/24/22
|
2/22/23
|
2/14/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
72.75
|
64.23
|
64.52
|
69.21
|
79.2
|
64
|
62.45
|
61.92
|
70.68
|
59.52
|
61.86
|
64.4
|
75.77
|
75.19
|
78.5
|
EBITDA
1 |
-41.09
|
-47.14
|
-42.8
|
-41.9
|
-43.4
|
-44.6
|
-45.3
|
-38.54
|
-36.9
|
-45.65
|
-39.82
|
-36.85
|
-35.45
|
-17.07
|
-14.77
|
EBIT
1 |
-47.42
|
-70.48
|
-69.4
|
-71.12
|
-64.84
|
-67.01
|
-67.23
|
-64.47
|
-56.96
|
-75.03
|
-59.73
|
-57.44
|
-56.48
|
-37.99
|
-36.33
|
Operating Margin
|
-65.19%
|
-109.73%
|
-107.58%
|
-102.77%
|
-81.87%
|
-104.71%
|
-107.66%
|
-104.11%
|
-80.58%
|
-126.06%
|
-96.56%
|
-89.2%
|
-74.54%
|
-50.53%
|
-46.27%
|
Earnings before Tax (EBT)
1 |
-47.21
|
-70.37
|
-69.19
|
-69.89
|
-60.83
|
-396.4
|
-92.17
|
-135.4
|
-48.78
|
-71.25
|
-56.69
|
-54.98
|
-55.78
|
-38.42
|
-35.6
|
Net income
1 |
-47.79
|
-70.04
|
-69.14
|
-70.08
|
-61.16
|
-397.7
|
-92.48
|
-136.4
|
-48.59
|
-72.1
|
-57
|
-54.01
|
-54.5
|
-35.77
|
-32.44
|
Net margin
|
-65.69%
|
-109.04%
|
-107.17%
|
-101.26%
|
-77.23%
|
-621.38%
|
-148.09%
|
-220.3%
|
-68.75%
|
-121.14%
|
-92.13%
|
-83.87%
|
-71.93%
|
-47.58%
|
-41.32%
|
EPS
2 |
-0.1800
|
-0.2600
|
-0.2500
|
-0.2500
|
-0.2200
|
-1.420
|
-0.3300
|
-0.4800
|
-0.1700
|
-0.2500
|
-0.1950
|
-0.1830
|
-0.1842
|
-0.1198
|
-0.1091
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/24/22
|
5/9/22
|
8/4/22
|
11/7/22
|
2/22/23
|
5/3/23
|
8/2/23
|
11/1/23
|
2/14/24
|
5/1/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
1,042
|
746
|
539
|
372
|
249
|
207
|
201
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-116
|
-142
|
-193
|
-164
|
-176
|
-57.3
|
11.5
|
ROE (net income / shareholders' equity)
|
-
|
-47.1%
|
-13.5%
|
-23.5%
|
-88.4%
|
-54.1%
|
-43.2%
|
-36.8%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
5.200
|
4.730
|
3.840
|
1.610
|
0.9700
|
0.7100
|
0.5900
|
Cash Flow per Share
2 |
-
|
-1.140
|
-0.5600
|
-0.7000
|
-0.5200
|
-0.4600
|
-0.0700
|
-
|
Capex
1 |
-
|
3.32
|
0.56
|
0.29
|
0.19
|
10.5
|
8.36
|
6.96
|
Capex / Sales
|
-
|
1.35%
|
0.22%
|
0.11%
|
0.07%
|
4.03%
|
2.58%
|
1.9%
|
Announcement Date
|
8/24/20
|
3/24/21
|
2/24/22
|
2/22/23
|
2/14/24
|
-
|
-
|
-
|
Last Close Price
0.4862
USD Average target price
1.828
USD Spread / Average Target +275.93% Consensus |
1st Jan change
|
Capi.
|
---|
| -67.37% | 142M | | +57.70% | 2.97B | | -40.14% | 2.17B | | +115.18% | 703M | | +10.24% | 489M |
Telemedicine Services
|